Acer Therapeutics Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Newton, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Acer Therapeutics Inc. has filed 1,254 SEC EDGAR filings since 08 Mar 1999

SEC filing history

Showing 451-475 of 785 matching filings.

Per page
25
Current page
19
424B5 File 333-208314

424B5

Filing date
25 Mar 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33004

8-K

Filing date
25 Mar 2016
Reporting date
25 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
22 Mar 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3/A File 333-208314

S-3/A

Filing date
18 Mar 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33004

CURRENT REPORT

Filing date
15 Mar 2016
Reporting date
14 Mar 2016
Next action
Verify source filing
10-K File 001-33004

ANNUAL REPORT

Filing date
15 Mar 2016
Reporting date
31 Dec 2015
Next action
Verify source filing
8-K File 001-33004

CURRENT REPORT

Filing date
02 Mar 2016
Reporting date
02 Mar 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-81104

SC 13G/A

Filing date
05 Feb 2016
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
04 Jan 2016
Reporting date
31 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
04 Jan 2016
Reporting date
31 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
04 Jan 2016
Reporting date
31 Dec 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
10 Dec 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-208314

FORM S-3

Filing date
02 Dec 2015
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33004

CURRENT REPORT

Filing date
10 Nov 2015
Reporting date
10 Nov 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-33004

QUARTERLY REPORT

Filing date
10 Nov 2015
Reporting date
30 Sep 2015
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
03 Nov 2015
Reporting date
26 Oct 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33004

CURRENT REPORT

Filing date
15 Oct 2015
Reporting date
15 Oct 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
02 Oct 2015
Reporting date
30 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
02 Oct 2015
Reporting date
30 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
02 Oct 2015
Reporting date
30 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33004

CURRENT REPORT

Filing date
28 Sep 2015
Reporting date
28 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33004

CURRENT REPORT

Filing date
03 Sep 2015
Reporting date
28 Aug 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33004

CURRENT REPORT

Filing date
02 Sep 2015
Reporting date
02 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33004

OPEXA THERAPEUTICS, INC. 8-K

Filing date
01 Sep 2015
Reporting date
01 Sep 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33004

CURRENT REPORT

Filing date
12 Aug 2015
Reporting date
12 Aug 2015
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .